Application Deadline: March 3, 2025
LOCATION: USA
In 2025, in partnership with leading patient advocacy organizations, this grant mechanism will focus on furthering the understanding of the development, prevention, and therapy of resistance by supporting projects that seek to identify, characterize, treat or prevent resistance to lung cancer therapies. Work supported through this mechanism will address important mechanistic questions and developmental therapeutics across histological subtypes of lung cancer (including lung adenocarcinoma, squamous cell carcinoma and small cell lung cancer) and across the care continuum including newly designed targeted therapies and immunotherapies.
ELIGIBILITY:
Investigators must be affiliated with a non-profit academic or research institution and must be post-doctoral researchers, clinical fellows, or early-career and mid-career investigators with less than ten years’ experience since their initial faculty appointment.
Applicants from US-based and international institutions are eligible to apply and may hold any residency/citizenship status.
Applicants are prohibited from applying if they have received funding from the LCRF within the last 4 years.
Applicants are prohibited from applying in more than one of LCRF’s funding tracks in the same cycle.
Senior investigators with more than ten years’ experience since faculty appointment are generally not eligible for funding and are encouraged to mentor a junior team member through the application process. However, exceptions will be made for investigators with more than ten years’ experience in other disease areas or topics.
Ineligible investigators with these or other special circumstances may request review by contacting the LCRF grants office (see Inquiries section below) before submitting an application and at least a week before submission deadline.
Ineligible applications and new requests under special circumstances will not be considered after submission deadline
BENEFIT:
The maximum award amount is $150,000 for a period of two years (disbursed at $75,000 per year). Additional budget requirements and considerations include the following:
Funding from this award may not be used to support institutional indirect / facilities and administrative costs.
The LCRF grant must be the primary source of support for the project. Additional secondary funding (e.g. for core services support) is permitted.
There is no limit on the amount of salary support that may be requested. However, appropriate justification for all budget items is required. Any salary requests in excess of 20% of the total budget must be explicitly justified. Queries related to justification should be sent to LCRF at least a week before submission deadline.
Any equipment costs must be limited and directly applicable to the research project (i.e. large, general equipment costs are not permitted).
Direct patient care costs reimbursable by other sources may not be included.
Travel and publication costs are permitted.